title: Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's disease.
authors.forename: Petros N
authors.initials: PN
authors.lastname: Karamanakos
authors.forename: Periklis
authors.initials: P
authors.lastname: Pappas
authors.forename: Marios
authors.initials: M
authors.lastname: Marselos
mesh_terms: D000818:Animals; D000978:Antiparkinson Agents / Q000009:adverse effects*; D002744:Chlorpheniramine / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D007980:Levodopa / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*
chemical_list: D000978:Antiparkinson Agents; D017366:Serotonin Receptor Agonists; D002744:Chlorpheniramine; D007980:Levodopa